U.S. Stem Cell, Inc.
OTC: USRM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Tomas
- Employees
- 11
- Headquarters
- Sunrise, United States
- IPO year
- 2008
- Market cap
- $64.2K
- Website
- https://www.us-stemcell.com
Loading USRM…
Loading profile data…Frequently asked questions about USRM
What does U.S. Stem Cell, Inc. (USRM) do?
U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of medical conditions, including both chronic and acute forms of heart damage, along with various vascular and autoimmune disorders. Among its leadin...
Where does USRM trade?
U.S. Stem Cell, Inc. (USRM) trades on the Other OTC.
What sector is USRM in?
U.S. Stem Cell, Inc. (USRM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of U.S. Stem Cell, Inc.?
Michael Tomas is the chief executive officer of U.S. Stem Cell, Inc. (USRM).
Where is U.S. Stem Cell, Inc. headquartered?
U.S. Stem Cell, Inc. is headquartered in United States.
Does USRM pay a dividend?
U.S. Stem Cell, Inc. (USRM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did USRM go public?
U.S. Stem Cell, Inc. (USRM) completed its initial public offering in 2008.